Seminars in Hematology
Volume 43, Issue 3 , Pages 157-166 , July 2006

Dyskeratosis Congenita

  • Tom Vulliamy

      Affiliations

    • Corresponding Author InformationAddress correspondence to Tom Vulliamy, PhD, Department of Haematology, Imperial College London, Commonwealth Building, Hammersmith Hospital, London W12 ONN, UK.
    • ,
  • Inderjeet Dokal

References 

  1. Sirinavin C , Trowbridge AA . Dyskeratosis congenita: Clinical features and genetic aspects. Report of a family and review of the literature . J Med Genet . 1975;12:339–354
  2. Drachtman RA , Alter BP . Dyskeratosis congenita . Dermatol Clin . 1995;13:33–39
  3. Knight S , Vulliamy T , Copplestone A , Gluckman E , Mason PJ , Dokal I . Dyskeratosis Congenita (DC) Registry (Identification of new features of DC) . Br J Haematol . 1998;103:990–996
  4. Dokal I , Vulliamy T . Telomerase deficiency and human disease . In:  de Lange T ,  Lundblad V ,  Blackburn E editor. Telomeres. Cold Spring Harbor . NY: Cold Spring Harbor Laboratory Press; 2006;p. 139–161
  5. Aalfs CM , van den Berg H , Barth PG , Hennekam RC . The Hoyeraal-Hreidarsson syndrome (The fourth case of a separate entity with prenatal growth retardation, progressive pancytopenia and cerebellar hypoplasia) . Eur J Pediatr . 1995;154:304–308
  6. Knight SW , Heiss NS , Vulliamy TJ , Aalfs CM , McMahon C , Richmond P , et al.  Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1 . Br J Haematol . 1999;107:335–339
  7. Cossu F , Vulliamy TJ , Badiali M , Cao A , Dokal I . Bone marrow transplantation in an infant with Hoyerall-Hreidarrson syndrome associated with severe combined immune deficiency (T+B-NK- SCID) and a novel DKC1 mutation . Br J Haematol . 2002;119:765–768
  8. De Boeck K , Degreef H , Verwilghen R , Corbeel L , Casteels-Van Daele M . Thrombocytopenia (First symptom in a patient with dyskeratosis congenita) . Pediatrics . 1981;67:898–903
  9. Russo CL , Glader BE , Israel RJ , Galasso F . Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor . Lancet . 1990;336:751–752
  10. Alter BP , Gardner FH , Hall RE . Treatment of dyskeratosis congenita with granulocyte colony-stimulating factor and erythropoietin . Br J Haematol . 1997;97:309–311
  11. Rocha V , Devergie A , Socie G , Ribaud P , Esperou H , Parquet N , et al.  Unusual complications after bone marrow transplantation for dyskeratosis congenita . Br J Haematol . 1998;103:243–248
  12. M’kacher R , Laithier V , Valent A , Delhommeau F , Violot D , Deutsch E , et al.  Sensitivity to radiation and alkylating agent of peripheral lymphocytes and fibroblasts in a Hoyeraal-Hreidarsson syndrome patient . Pediatr Hematol Oncol . 2003;20:651–656
  13. Cengiz M , Celebioglu B , Ozyar E , Atahan L . Unusual hypersensitivity to radiation therapy in a patient with dyskeratosis congenita syndrome . Oral Oncol . 2004;40:758–759
  14. Dror Y , Freedman MH , Leaker M , Verbeek J , Armstrong CA , Saunders FE . Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita . Bone Marrow Transplant . 2003;31:847–850
  15. Gungor T , Corbacioglu S , Storb R , Seger RA . Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of dyskeratosis congenita . Bone Marrow Transplant . 2003;31:407–410
  16. Pai GS , Yan Y , DeBauche DM , Stanley WS , Paul SR . Bleomycin hypersensitivity in dyskeratosis congenita fibroblasts, lymphocytes, and transformed lymphoblasts . Cytogenet Cell Genet . 1989;52:186–189
  17. Coulthard S , Chase A , Pickard J , Goldman J , Dokal I . Chromosomal breakage analysis in dyskeratosis congenita peripheral blood lymphocytes . Br J Haematol . 1998;102:1162–1164
  18. Vulliamy TJ , Marrone M , Knight S , Walne A , Mason PJ , Dokal I . Mutations in dyskeratosis congenita (Their impact on telomere length and the diversity of clinical presentation) . Blood . 2006;107:2680–2685
  19. Connor JM , Gatherer D , Gray FC , Pirrit LA , Affara NA . Assignment of the gene for dyskeratosis congenita to Xq28 . Hum Genet . 1986;72:348–351
  20. Knight SW , Vulliamy TJ , Heiss N , Matthijs G , Devriendt K , Connor JM , et al.  1.4Mb candidate region for X-linked dyskeratosis congenita defined by combined haplotype and X-chromosome inactivation analysis . J Med Genet . 1998;35:993–996
  21. Heiss NS , Knight SW , Vulliamy TJ , Klauk SM , Wiemann S , Mason PJ , et al.  X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions . Nat Genet . 1998;19:32–38
  22. He J , Navarrete S , Jasinski M , Vulliamy T , Dokal I , Bessler M , et al.  Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice . Oncogene . 2002;21:7740–7744
  23. Heiss NS , Girod A , Salowsky R , Wiemann S , Pepperkok R , Poustka A . Dyskerin localizes to the nucleolus and its mislocalization is unlikely to play a role in the pathogenesis of dyskeratosis congenita . Hum Mol Genet . 1999;8:2515–2524
  24. Youssoufian H , Gharibyan V , Qatanani M . Analysis of epitope-tagged forms of the dyskeratosis congenital protein (dyskerin) (Identification of a nuclear localization signal) . Blood Cells Mol Dis . 1999;25:305–309
  25. Meier UT , Blobel G . NAP57, a mammalian nucleolar protein with a putative homolog in yeast and bacteria . J Cell Biol . 1994;127:1505–1514
  26. Jiang W , Middleton K , Yoon HJ , Fouquet C , Carbon J . An essential yeast protein, CBF5p, binds in vitro to centromeres and microtubules . Mol Cell Biol . 1993;13:4884–4893
  27. Aravind L , Koonin EV . Novel predicted RNA-binding domains associated with the translation machinery . J Mol Evol . 1999;48:291–302
  28. Tollervey D , Kiss T . Function and synthesis of small nucleolar RNAs . Curr Opin Cell Biol . 1997;9:337–342
  29. Wang C , Meier UT . Architecture and assembly of mammalian H/ACA small nucleolar and telomerase ribonucleoproteins . EMBO J . 2004;23:1857–1867
  30. Meier UT . The many facets of H/ACA ribonucleoproteins . Chromosoma . 2005;114:1–14
  31. Luzzatto L , Karadimitris A . Dyskeratosis and ribosomal rebellion . Nat Genet . 1998;19:6–7
  32. Cadwell C , Yoon HJ , Zebarjadian Y , Carbon J . The yeast nucleolar protein Cbf5p is involved in rRNA biosynthesis and interacts genetically with the RNA polymerase I transcription factor RRN3 . Mol Cell Biol . 1997;17:6175–6183
  33. Henras AK , Capeyrou R , Henry Y , Caizergues-Ferrer M . Cbf5p, the putative pseudouridine synthase of H/ACA-type snoRNPs, can form a complex with Gar1p and Nop10p in absence of Nhp2p and box H/ACA snoRNAs . RNA . 2004;10:1704–1712
  34. Hamma T , Reichow SL , Varani G , Ferre-D’Amare AR . The Cbf5-Nop10 complex is a molecular bracket that organizes box H/ACA RNPs . Nat Struct Mol Biol . 2005;12:1101–1107
  35. Rashid R , Liang B , Baker DL , Youssef OA , He Y , Phipps K , et al.  Crystal structure of a Cbf5-Nop10-Gar1 complex and implications in RNA-guided pseudouridylation and dyskeratosis congenita . Mol Cell . 2006;21:249–260
  36. Zebarjadian Y , King T , Fournier MJ , Clarke L , Carbon J . Point mutations in yeast CBF5 can abolish in vivo pseudouridylation of rRNA . Mol Cell Biol . 1999;19:7461–7472
  37. Blackburn EH . Telomeres and telomerase (Their mechanisms of action and the effects of altering their functions) . FEBS Lett . 2005;579:859–862
  38. Shay JW , Wright WE . Senescence and immortalization (Role of telomeres and telomerase) . Carcinogenesis . 2005;26:867–874
  39. Chen JL , Greider CW . Telomerase RNA structure and function (Implications for dyskeratosis congenita) . Trends Biochem Sci . 2004;29:183–192
  40. Nakamura TM , Morin GB , Chapman KB , Weinrich SL , Andrews WH , Lingner J , et al.  Telomerase catalytic subunit homologs from fission yeast and human . Science . 1997;277:955–959
  41. Mitchell JR , Cheng J , Collins K . A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end . Mol Cell Biol . 1999;19:567–576
  42. Dez C , Henras A , Faucon B , Lafontaine D , Caizergues-Ferrer M , Henry Y . Stable expression in yeast of the mature form of human telomerase RNA depends on its association with the box H/ACA small nucleolar RNP proteins Cbf5p, Nhp2p and Nop10p . Nucleic Acids Res . 2001;29:598–603
  43. Pogacic V , Dragon F , Filipowicz W . Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10 . Mol Cell Biol . 2000;20:9028–9040
  44. Mitchell JR , Wood E , Collins K . A telomerase component is defective in the human disease dyskeratosis congenita . Nature . 1999;402:551–555
  45. Vulliamy TJ , Knight SW , Mason PJ , Dokal I . Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita . Blood Cells Mol Dis . 2001;27:353–357
  46. Wong JM , Kyasa MJ , Hutchins L , Collins K . Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita . Hum Genet . 2004;115:448–455
  47. Montanaro L , Chilla A , Trere D , Pession A , Govoni M , Tazzari PL , et al.  Increased mortality rate and not impaired ribosomal biogenesis is responsible for proliferative defect in dyskeratosis congenita cell lines . J Invest Dermatol . 2002;118:193–198
  48. Montanaro L , Tazzari PL , Derenzini M . Enhanced telomere shortening in transformed lymphoblasts from patients with X linked dyskeratosis . J Clin Pathol . 2003;56:583–586
  49. Ruggero D , Grisendi S , Piazza F , Rego E , Mari F , Rao PH , et al.  Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification . Science . 2003;299:259–262
  50. Mochizuki Y , He J , Kulkarni S , Bessler M , Mason PJ . Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing . Proc Natl Acad Sci U S A . 2004;101:10756–10761
  51. Vulliamy T , Marrone A , Goldman F , Dearlove A , Bessler M , Mason PJ , et al.  The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita . Nature . 2001;413:432–435
  52. Vulliamy T , Marrone A , Szydlo R , Walne A , Mason PJ , Dokal I . Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC . Nature Genetics . 2004;36:447–449
  53. Vulliamy TJ , Marrone A , Dokal I , Mason PJ . Association between aplastic anaemia and mutations in telomerase RNA . Lancet . 2002;359:2168–2170
  54. Fogarty PF , Yamaguchi H , Wiestner A , Baerlocher GM , Sloand E , Zeng WS , et al.  Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA . Lancet . 2003;362:1628–1630
  55. Yamaguchi H , Baerlocher GM , Lansdorp PM , Chanock SJ , Nunez O , Sloand E , et al.  Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome . Blood . 2003;102:916–918
  56. Keith WN , Vulliamy T , Zhao J , Cem A , Erzik C , Bilsland A , et al.  A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with paroxysmal nocturnal haemoglobinuria . BMC Blood Disorders . 2004;4:3–7
  57. Ly H , Calado RT , Allard P , Baerlocher GM , Lansdorp PM , Young NS , et al.  Functional characterization of telomerase RNA variants found in patients with hematologic disorders . Blood . 2005;105:2332–2339
  58. Boultwood J , Fidler C , Kusec R , Rack K , Elliott PJ , Atoyebi O , et al.  Telomere length in myelodysplastic syndromes . Am J Hematol . 1997;56:266–271
  59. Comolli LR , Smirnov I , Xu L , Blackburn EH , James TL . A molecular switch underlies a human telomerase disease . Proc Natl Acad Sci U S A . 2002;99:16998–17003
  60. Theimer CA , Finger LD , Trantirek L , Feigon J . Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA . Proc Natl Acad Sci U S A . 2003;100:449–454
  61. Fu D , Collins K . Distinct biogenesis pathways for human telomerase RNA and H/ACA small nucleolar RNAs . Mol Cell . 2003;11:1361–1372
  62. Marrone A , Stevens D , Vulliamy T , Dokal I , Mason PJ . Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency . Blood . 2004;104:3936–3942
  63. Ly H , Schertzer M , Jastaniah W , Davis J , Yong SL , Ouyang Q , et al.  Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita . Blood . 2005;106:1246–1252
  64. Ren X , Gavory G , Li H , Ying L , Klenerman D , Balasubramanian S . Identification of a new RNA.RNA interaction site for human telomerase RNA (hTR) (Structural implications for hTR accumulation and a dyskeratosis congenita point mutation) . Nucleic Acids Res . 2003;31:6509–6515
  65. Cerone MA , Ward RJ , Londono-Vallejo JA , Autexier C . Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation . Cell Cycle . 2005;4:585–589
  66. Ly H , Blackburn EH , Parslow TG . Comprehensive structure-function analysis of the core domain of human telomerase RNA . Mol Cell Biol . 2003;23:6849–6856
  67. Goldman F , Bouarich R , Kulkarni S , Freeman S , Du HY , Harrington L , et al.  The effect of TERC haploinsufficiency on the inheritance of telomere length . Proc Natl Acad Sci U S A . 2005;102:17119–17124
  68. Blasco MA , Lee HW , Hande MP , Samper E , Lansdorp PM , DePinho RA , et al.  Telomere shortening and tumor formation by mouse cells lacking telomerase RNA . Cell . 1997;91:25–34
  69. Hathcock KS , Hemann MT , Opperman KK , Strong MA , Greider CW , Hodes RJ . Haploinsufficiency of mTR results in defects in telomere elongation . Proc Natl Acad Sci U S A . 2002;99:3591–3596
  70. Hao LY , Armanios M , Strong MA , Karim B , Feldser DM , Huso D , et al.  Short telomeres, even in the presence of telomerase, limit tissue renewal capacity . Cell . 2005;16:1121–1131
  71. Marrone A , Mason PJ . Dyskeratosis congenita . Cell Mol Life Sci . 2003;60:507–511
  72. Yamaguchi H , Calado RT , Ly H , Kajigaya S , Baerlocher GM , Chanock SJ , et al.  Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia . N Engl J Med . 2005;352:1413–1424
  73. Vulliamy TJ , Walne A , Baskaradas A , Mason PJ , Marrone A , Dokal I . Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure . Blood Cells Mol Dis . 2005;34:257–263
  74. Armanios M , Chen JL , Chang YP , Brodsky RA , Hawkins A , Griffin CA , et al.  Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita . Proc Natl Acad Sci U S A . 2005;102:15960–15964
  75. Chiang YJ , Hemann MT , Hathcock KS , Tessarollo L , Feigenbaum L , Hahn WC , et al.  Expression of telomerase RNA template, but not telomerase reverse transcriptase, is limiting for telomere length maintenance in vivo . Mol Cell Biol . 2004;24: 7024–3701
  76. Walne A , Vulliamy T , Marrone A , Dokal I . Genome wide linkage analysis suggests genetic heterogeneity in autosomal recessive dyskeratosis congenita, with one locus on chromosome 15 . Blood . 2005;106:307a; (abstr)
  77. Bagby GC , Alter B . Fanconi anemia . Semin Hematol . 2006;43:147–156

 Supported in part by the Wellcome Trust.

PII: S0037-1963(06)00075-8

doi: 10.1053/j.seminhematol.2006.04.001

Seminars in Hematology
Volume 43, Issue 3 , Pages 157-166 , July 2006

Article Tools

* Image Usage & Resolution